Skip to main content
. 2020 Mar 25;10(21):12135–12144. doi: 10.1039/d0ra00643b

Inhibition of cell growth by compounds selected after the initial screening.

graphic file with name d0ra00643b-u2.jpg
Compound R1 R2 GI50a (μM) ± SEMb
MDA-MB231 SKBR-3 MCF-7 MCF-10A
14 3-FC6H4 4-FC6H4 9.21 ± 0.38 >20 >20 >25
16 3-FC6H4 4-BrC6H4 13.13 ± 0.91 17.16 ± 1.07 >20 >25
17 3-FC6H4 4-MeC6H4 3.96 ± 0.17 >20 >20 >25
18 3-FC6H4 4-MeOC6H4 6.18 ± 0.43 16.63 ± 1.38 >20 >25
19 3-FC6H4 4-CF3OC6H4 8.56 ± 0.59 >20 18.22 ± 1.28 >25
36 4-ClC6H4 4-FC6H4 14.14 ± 1.52 19.40 ± 2.39 >20 >25
56 3-MeC6H4 4-MeC6H4 0.17 ± 0.02 1.26 ± 0.18 >20 >25
58 3-MeC6H4 4-CF3OC6H4 15.24 ± 1.01 >20 >20 >25
61 4-MeC6H4 2-FC6H4 12.25 ± 1.15 >20 >20 >25
62 4-MeC6H4 4-FC6H4 10.68 ± 0.73 >20 20.15 ± 1.95 >25
70 4-MeOC6H4 2-FC6H4 0.32 ± 0.04 >20 >20 >25
73 4-MeOC6H4 2-ClC6H4 0.23 ± 0.03 1.10 ± 0.01 >20 >25
74 4-MeOC6H4 3-ClC6H4 1.33 ± 0.17 0.18 ± 0.04 18.30 ± 1.11 >25
77 4-MeOC6H4 3-MeC6H4 0.95 ± 0.04 3.38 ± 0.36 >20 >25
78 4-MeOC6H4 2-MeOC6H4 13.25 ± 0.93 2.15 ± 0.12 >20 >25
81 4-MeOC6H4 3-Pyridyl 14.01 ± 1.33 15.58 ± 1.06 >20 >25
95 4-CF3OC6H4 2-MeOC6H4 12.77 ± 0.76 >20 >20 >25
99 4-CF3OC6H4 3-Pyridyl 11.52 ± 1.51 >20 >20 >25
100 4-Me2NC6H4 Ph 0.36 ± 0.07 4.19 ± 0.37 >20 >25
101 4-Me2NC6H4 2-FC6H4 0.06 ± 0.001 0.29 ± 0.04 >20 >25
102 4-Me2NC6H4 4-FC6H4 7.20 ± 0.94 >20 >20 >25
103 4-Me2NC6H4 2-MeOC6H4 4.17 ± 0.33 3.63 ± 0.23 >20 >25
110 4-BnOC6H4 Ph 13.44 ± 1.18 >20 >20 >25
120 2-Thienyl 4-BrC6H4 11.73 ± 1.39 >20 >20 >25
121 2-Thienyl 4-MeC6H4 13.88 ± 1.74 >20 >20 >25
Methotrexatec 0.01 ± 0.001 ND 5.79 ± 0.47 ND
Nilotinibc 0.04 ± 0.001 9.60 ± 0.51 ND ND
a

Concentration (μM) required to inhibit tumor cell growth by 50%, values are mean of three independent experiments.

b

Standard error of the mean.

c

Positive controls, ND = not determined.